nodes	percent_of_prediction	percent_of_DWPC	metapath
Itraconazole—CYP1A1—Dacarbazine—pancreatic cancer	0.0564	0.0733	CbGbCtD
Itraconazole—CYP1A1—Tamoxifen—pancreatic cancer	0.0449	0.0583	CbGbCtD
Itraconazole—CYP2E1—Dacarbazine—pancreatic cancer	0.0436	0.0566	CbGbCtD
Itraconazole—CYP1A1—Erlotinib—pancreatic cancer	0.0382	0.0496	CbGbCtD
Itraconazole—CYP3A7—Tamoxifen—pancreatic cancer	0.0359	0.0466	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0359	0.0466	CbGbCtD
Itraconazole—CYP2E1—Tamoxifen—pancreatic cancer	0.0347	0.045	CbGbCtD
Itraconazole—CYP2B6—Tamoxifen—pancreatic cancer	0.0342	0.0444	CbGbCtD
Itraconazole—CYP3A7—Irinotecan—pancreatic cancer	0.0276	0.0358	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0276	0.0358	CbGbCtD
Itraconazole—CYP3A5—Tamoxifen—pancreatic cancer	0.0269	0.035	CbGbCtD
Itraconazole—CYP2B6—Irinotecan—pancreatic cancer	0.0263	0.0341	CbGbCtD
Itraconazole—CYP3A5—Erlotinib—pancreatic cancer	0.0229	0.0297	CbGbCtD
Itraconazole—CYP3A5—Irinotecan—pancreatic cancer	0.0207	0.0269	CbGbCtD
Itraconazole—CYP3A7—Docetaxel—pancreatic cancer	0.0202	0.0262	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0202	0.0262	CbGbCtD
Itraconazole—CYP3A7—Sunitinib—pancreatic cancer	0.0201	0.0261	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0201	0.0261	CbGbCtD
Itraconazole—ABCB1—Tamoxifen—pancreatic cancer	0.0175	0.0228	CbGbCtD
Itraconazole—CYP2D6—Tamoxifen—pancreatic cancer	0.0165	0.0215	CbGbCtD
Itraconazole—CYP3A5—Docetaxel—pancreatic cancer	0.0152	0.0197	CbGbCtD
Itraconazole—ABCB1—Gemcitabine—pancreatic cancer	0.0151	0.0196	CbGbCtD
Itraconazole—CYP3A5—Sunitinib—pancreatic cancer	0.0151	0.0196	CbGbCtD
Itraconazole—ABCB1—Erlotinib—pancreatic cancer	0.0149	0.0194	CbGbCtD
Itraconazole—CYP2B6—Doxorubicin—pancreatic cancer	0.0143	0.0186	CbGbCtD
Itraconazole—CYP2D6—Erlotinib—pancreatic cancer	0.014	0.0182	CbGbCtD
Itraconazole—ABCB1—Irinotecan—pancreatic cancer	0.0135	0.0175	CbGbCtD
Itraconazole—CYP3A4—Tamoxifen—pancreatic cancer	0.0105	0.0136	CbGbCtD
Itraconazole—ABCB1—Docetaxel—pancreatic cancer	0.00986	0.0128	CbGbCtD
Itraconazole—ABCB1—Sunitinib—pancreatic cancer	0.00982	0.0128	CbGbCtD
Itraconazole—CYP3A4—Erlotinib—pancreatic cancer	0.00893	0.0116	CbGbCtD
Itraconazole—CYP3A4—Irinotecan—pancreatic cancer	0.00806	0.0105	CbGbCtD
Itraconazole—ABCB1—Doxorubicin—pancreatic cancer	0.00735	0.00955	CbGbCtD
Itraconazole—CYP2D6—Doxorubicin—pancreatic cancer	0.00693	0.009	CbGbCtD
Itraconazole—CYP3A4—Docetaxel—pancreatic cancer	0.00591	0.00768	CbGbCtD
Itraconazole—CYP3A4—Sunitinib—pancreatic cancer	0.00588	0.00764	CbGbCtD
Itraconazole—CYP3A4—Doxorubicin—pancreatic cancer	0.00441	0.00572	CbGbCtD
Itraconazole—Infestation—Epirubicin—pancreatic cancer	0.000122	0.00053	CcSEcCtD
Itraconazole—Bronchitis—Doxorubicin—pancreatic cancer	0.000122	0.000529	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000121	0.000526	CcSEcCtD
Itraconazole—Chest pain—Docetaxel—pancreatic cancer	0.00012	0.000523	CcSEcCtD
Itraconazole—Arthralgia—Docetaxel—pancreatic cancer	0.00012	0.000523	CcSEcCtD
Itraconazole—Myalgia—Docetaxel—pancreatic cancer	0.00012	0.000523	CcSEcCtD
Itraconazole—Nausea—Sunitinib—pancreatic cancer	0.00012	0.000523	CcSEcCtD
Itraconazole—Renal failure—Epirubicin—pancreatic cancer	0.00012	0.000521	CcSEcCtD
Itraconazole—Asthenia—Irinotecan—pancreatic cancer	0.00012	0.000521	CcSEcCtD
Itraconazole—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00012	0.00052	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00012	0.00052	CcSEcCtD
Itraconazole—Jaundice—Epirubicin—pancreatic cancer	0.000119	0.000517	CcSEcCtD
Itraconazole—Urinary tract infection—Epirubicin—pancreatic cancer	0.000119	0.000516	CcSEcCtD
Itraconazole—Neutropenia—Doxorubicin—pancreatic cancer	0.000118	0.000515	CcSEcCtD
Itraconazole—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000118	0.000512	CcSEcCtD
Itraconazole—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000118	0.000512	CcSEcCtD
Itraconazole—Pollakiuria—Doxorubicin—pancreatic cancer	0.000117	0.000508	CcSEcCtD
Itraconazole—Asthenia—Gemcitabine—pancreatic cancer	0.000117	0.000507	CcSEcCtD
Itraconazole—Haematuria—Epirubicin—pancreatic cancer	0.000116	0.000506	CcSEcCtD
Itraconazole—Confusional state—Docetaxel—pancreatic cancer	0.000116	0.000506	CcSEcCtD
Itraconazole—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000116	0.000502	CcSEcCtD
Itraconazole—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000115	0.000502	CcSEcCtD
Itraconazole—Oedema—Docetaxel—pancreatic cancer	0.000115	0.000502	CcSEcCtD
Itraconazole—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000115	0.000502	CcSEcCtD
Itraconazole—Pruritus—Gemcitabine—pancreatic cancer	0.000115	0.0005	CcSEcCtD
Itraconazole—Infection—Docetaxel—pancreatic cancer	0.000115	0.000498	CcSEcCtD
Itraconazole—Weight decreased—Doxorubicin—pancreatic cancer	0.000115	0.000498	CcSEcCtD
Itraconazole—Sinusitis—Epirubicin—pancreatic cancer	0.000114	0.000498	CcSEcCtD
Itraconazole—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000114	0.000497	CcSEcCtD
Itraconazole—Diarrhoea—Irinotecan—pancreatic cancer	0.000114	0.000496	CcSEcCtD
Itraconazole—Agranulocytosis—Epirubicin—pancreatic cancer	0.000114	0.000495	CcSEcCtD
Itraconazole—Pneumonia—Doxorubicin—pancreatic cancer	0.000114	0.000494	CcSEcCtD
Itraconazole—Shock—Docetaxel—pancreatic cancer	0.000114	0.000493	CcSEcCtD
Itraconazole—Nervous system disorder—Docetaxel—pancreatic cancer	0.000113	0.000492	CcSEcCtD
Itraconazole—Pruritus—Fluorouracil—pancreatic cancer	0.000113	0.000492	CcSEcCtD
Itraconazole—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000113	0.000491	CcSEcCtD
Itraconazole—Infestation NOS—Doxorubicin—pancreatic cancer	0.000113	0.000491	CcSEcCtD
Itraconazole—Infestation—Doxorubicin—pancreatic cancer	0.000113	0.000491	CcSEcCtD
Itraconazole—Drowsiness—Doxorubicin—pancreatic cancer	0.000113	0.000491	CcSEcCtD
Itraconazole—Tachycardia—Docetaxel—pancreatic cancer	0.000113	0.000489	CcSEcCtD
Itraconazole—Skin disorder—Docetaxel—pancreatic cancer	0.000112	0.000487	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000112	0.000487	CcSEcCtD
Itraconazole—Diarrhoea—Gemcitabine—pancreatic cancer	0.000111	0.000484	CcSEcCtD
Itraconazole—Renal failure—Doxorubicin—pancreatic cancer	0.000111	0.000482	CcSEcCtD
Itraconazole—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000111	0.000481	CcSEcCtD
Itraconazole—Dizziness—Irinotecan—pancreatic cancer	0.00011	0.00048	CcSEcCtD
Itraconazole—Jaundice—Doxorubicin—pancreatic cancer	0.00011	0.000478	CcSEcCtD
Itraconazole—Anorexia—Docetaxel—pancreatic cancer	0.00011	0.000478	CcSEcCtD
Itraconazole—Rhinitis—Epirubicin—pancreatic cancer	0.00011	0.000477	CcSEcCtD
Itraconazole—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00011	0.000477	CcSEcCtD
Itraconazole—Hepatitis—Epirubicin—pancreatic cancer	0.00011	0.000476	CcSEcCtD
Itraconazole—Diarrhoea—Fluorouracil—pancreatic cancer	0.000109	0.000475	CcSEcCtD
Itraconazole—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000109	0.000474	CcSEcCtD
Itraconazole—Pharyngitis—Epirubicin—pancreatic cancer	0.000109	0.000473	CcSEcCtD
Itraconazole—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000108	0.00047	CcSEcCtD
Itraconazole—Oedema peripheral—Epirubicin—pancreatic cancer	0.000108	0.000469	CcSEcCtD
Itraconazole—Hypotension—Docetaxel—pancreatic cancer	0.000108	0.000469	CcSEcCtD
Itraconazole—Haematuria—Doxorubicin—pancreatic cancer	0.000108	0.000468	CcSEcCtD
Itraconazole—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000108	0.000468	CcSEcCtD
Itraconazole—Urethral disorder—Epirubicin—pancreatic cancer	0.000107	0.000467	CcSEcCtD
Itraconazole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000107	0.000464	CcSEcCtD
Itraconazole—Vomiting—Irinotecan—pancreatic cancer	0.000106	0.000461	CcSEcCtD
Itraconazole—Sinusitis—Doxorubicin—pancreatic cancer	0.000106	0.00046	CcSEcCtD
Itraconazole—Dizziness—Fluorouracil—pancreatic cancer	0.000106	0.00046	CcSEcCtD
Itraconazole—Visual impairment—Epirubicin—pancreatic cancer	0.000106	0.000459	CcSEcCtD
Itraconazole—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000105	0.000458	CcSEcCtD
Itraconazole—Rash—Irinotecan—pancreatic cancer	0.000105	0.000457	CcSEcCtD
Itraconazole—Dermatitis—Irinotecan—pancreatic cancer	0.000105	0.000457	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000105	0.000457	CcSEcCtD
Itraconazole—Headache—Irinotecan—pancreatic cancer	0.000105	0.000455	CcSEcCtD
Itraconazole—Insomnia—Docetaxel—pancreatic cancer	0.000104	0.000454	CcSEcCtD
Itraconazole—Paraesthesia—Docetaxel—pancreatic cancer	0.000104	0.00045	CcSEcCtD
Itraconazole—Erythema multiforme—Epirubicin—pancreatic cancer	0.000104	0.00045	CcSEcCtD
Itraconazole—Vomiting—Gemcitabine—pancreatic cancer	0.000103	0.000449	CcSEcCtD
Itraconazole—Dyspnoea—Docetaxel—pancreatic cancer	0.000103	0.000447	CcSEcCtD
Itraconazole—Somnolence—Docetaxel—pancreatic cancer	0.000103	0.000446	CcSEcCtD
Itraconazole—Rash—Gemcitabine—pancreatic cancer	0.000103	0.000446	CcSEcCtD
Itraconazole—Dermatitis—Gemcitabine—pancreatic cancer	0.000102	0.000445	CcSEcCtD
Itraconazole—Eye disorder—Epirubicin—pancreatic cancer	0.000102	0.000445	CcSEcCtD
Itraconazole—Tinnitus—Epirubicin—pancreatic cancer	0.000102	0.000444	CcSEcCtD
Itraconazole—Headache—Gemcitabine—pancreatic cancer	0.000102	0.000443	CcSEcCtD
Itraconazole—Cardiac disorder—Epirubicin—pancreatic cancer	0.000102	0.000442	CcSEcCtD
Itraconazole—Vomiting—Fluorouracil—pancreatic cancer	0.000102	0.000442	CcSEcCtD
Itraconazole—Rhinitis—Doxorubicin—pancreatic cancer	0.000102	0.000442	CcSEcCtD
Itraconazole—Dyspepsia—Docetaxel—pancreatic cancer	0.000102	0.000441	CcSEcCtD
Itraconazole—Hepatitis—Doxorubicin—pancreatic cancer	0.000101	0.000441	CcSEcCtD
Itraconazole—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000101	0.000438	CcSEcCtD
Itraconazole—Rash—Fluorouracil—pancreatic cancer	0.000101	0.000438	CcSEcCtD
Itraconazole—Dermatitis—Fluorouracil—pancreatic cancer	0.000101	0.000438	CcSEcCtD
Itraconazole—Pharyngitis—Doxorubicin—pancreatic cancer	0.000101	0.000437	CcSEcCtD
Itraconazole—Decreased appetite—Docetaxel—pancreatic cancer	0.0001	0.000436	CcSEcCtD
Itraconazole—Headache—Fluorouracil—pancreatic cancer	0.0001	0.000435	CcSEcCtD
Itraconazole—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.0001	0.000435	CcSEcCtD
Itraconazole—Oedema peripheral—Doxorubicin—pancreatic cancer	9.98e-05	0.000434	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.96e-05	0.000433	CcSEcCtD
Itraconazole—Connective tissue disorder—Doxorubicin—pancreatic cancer	9.96e-05	0.000433	CcSEcCtD
Itraconazole—Fatigue—Docetaxel—pancreatic cancer	9.95e-05	0.000432	CcSEcCtD
Itraconazole—Angiopathy—Epirubicin—pancreatic cancer	9.94e-05	0.000432	CcSEcCtD
Itraconazole—Urethral disorder—Doxorubicin—pancreatic cancer	9.94e-05	0.000432	CcSEcCtD
Itraconazole—Nausea—Irinotecan—pancreatic cancer	9.91e-05	0.000431	CcSEcCtD
Itraconazole—Immune system disorder—Epirubicin—pancreatic cancer	9.89e-05	0.00043	CcSEcCtD
Itraconazole—Mediastinal disorder—Epirubicin—pancreatic cancer	9.87e-05	0.000429	CcSEcCtD
Itraconazole—Pain—Docetaxel—pancreatic cancer	9.87e-05	0.000429	CcSEcCtD
Itraconazole—Constipation—Docetaxel—pancreatic cancer	9.87e-05	0.000429	CcSEcCtD
Itraconazole—Chills—Epirubicin—pancreatic cancer	9.83e-05	0.000427	CcSEcCtD
Itraconazole—Arrhythmia—Epirubicin—pancreatic cancer	9.79e-05	0.000425	CcSEcCtD
Itraconazole—Visual impairment—Doxorubicin—pancreatic cancer	9.77e-05	0.000425	CcSEcCtD
Itraconazole—Alopecia—Epirubicin—pancreatic cancer	9.68e-05	0.000421	CcSEcCtD
Itraconazole—Nausea—Gemcitabine—pancreatic cancer	9.66e-05	0.00042	CcSEcCtD
Itraconazole—Mental disorder—Epirubicin—pancreatic cancer	9.6e-05	0.000417	CcSEcCtD
Itraconazole—Erythema multiforme—Doxorubicin—pancreatic cancer	9.58e-05	0.000417	CcSEcCtD
Itraconazole—Malnutrition—Epirubicin—pancreatic cancer	9.54e-05	0.000415	CcSEcCtD
Itraconazole—Feeling abnormal—Docetaxel—pancreatic cancer	9.51e-05	0.000413	CcSEcCtD
Itraconazole—Nausea—Fluorouracil—pancreatic cancer	9.5e-05	0.000413	CcSEcCtD
Itraconazole—Eye disorder—Doxorubicin—pancreatic cancer	9.47e-05	0.000412	CcSEcCtD
Itraconazole—Tinnitus—Doxorubicin—pancreatic cancer	9.45e-05	0.000411	CcSEcCtD
Itraconazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	9.43e-05	0.00041	CcSEcCtD
Itraconazole—Cardiac disorder—Doxorubicin—pancreatic cancer	9.41e-05	0.000409	CcSEcCtD
Itraconazole—Flatulence—Epirubicin—pancreatic cancer	9.4e-05	0.000408	CcSEcCtD
Itraconazole—Dysgeusia—Epirubicin—pancreatic cancer	9.34e-05	0.000406	CcSEcCtD
Itraconazole—Back pain—Epirubicin—pancreatic cancer	9.22e-05	0.000401	CcSEcCtD
Itraconazole—Angiopathy—Doxorubicin—pancreatic cancer	9.2e-05	0.0004	CcSEcCtD
Itraconazole—Immune system disorder—Doxorubicin—pancreatic cancer	9.15e-05	0.000398	CcSEcCtD
Itraconazole—Mediastinal disorder—Doxorubicin—pancreatic cancer	9.13e-05	0.000397	CcSEcCtD
Itraconazole—Body temperature increased—Docetaxel—pancreatic cancer	9.12e-05	0.000396	CcSEcCtD
Itraconazole—Abdominal pain—Docetaxel—pancreatic cancer	9.12e-05	0.000396	CcSEcCtD
Itraconazole—Chills—Doxorubicin—pancreatic cancer	9.09e-05	0.000395	CcSEcCtD
Itraconazole—Arrhythmia—Doxorubicin—pancreatic cancer	9.05e-05	0.000394	CcSEcCtD
Itraconazole—Vision blurred—Epirubicin—pancreatic cancer	8.99e-05	0.000391	CcSEcCtD
Itraconazole—Alopecia—Doxorubicin—pancreatic cancer	8.96e-05	0.000389	CcSEcCtD
Itraconazole—Mental disorder—Doxorubicin—pancreatic cancer	8.88e-05	0.000386	CcSEcCtD
Itraconazole—Ill-defined disorder—Epirubicin—pancreatic cancer	8.85e-05	0.000385	CcSEcCtD
Itraconazole—Malnutrition—Doxorubicin—pancreatic cancer	8.82e-05	0.000384	CcSEcCtD
Itraconazole—Flatulence—Doxorubicin—pancreatic cancer	8.69e-05	0.000378	CcSEcCtD
Itraconazole—Dysgeusia—Doxorubicin—pancreatic cancer	8.64e-05	0.000376	CcSEcCtD
Itraconazole—Malaise—Epirubicin—pancreatic cancer	8.6e-05	0.000374	CcSEcCtD
Itraconazole—Vertigo—Epirubicin—pancreatic cancer	8.57e-05	0.000372	CcSEcCtD
Itraconazole—Syncope—Epirubicin—pancreatic cancer	8.55e-05	0.000372	CcSEcCtD
Itraconazole—Leukopenia—Epirubicin—pancreatic cancer	8.54e-05	0.000371	CcSEcCtD
Itraconazole—Back pain—Doxorubicin—pancreatic cancer	8.53e-05	0.000371	CcSEcCtD
Itraconazole—Hypersensitivity—Docetaxel—pancreatic cancer	8.5e-05	0.00037	CcSEcCtD
Itraconazole—Loss of consciousness—Epirubicin—pancreatic cancer	8.38e-05	0.000364	CcSEcCtD
Itraconazole—Cough—Epirubicin—pancreatic cancer	8.32e-05	0.000362	CcSEcCtD
Itraconazole—Vision blurred—Doxorubicin—pancreatic cancer	8.32e-05	0.000361	CcSEcCtD
Itraconazole—Asthenia—Docetaxel—pancreatic cancer	8.28e-05	0.00036	CcSEcCtD
Itraconazole—Hypertension—Epirubicin—pancreatic cancer	8.23e-05	0.000358	CcSEcCtD
Itraconazole—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.19e-05	0.000356	CcSEcCtD
Itraconazole—Pruritus—Docetaxel—pancreatic cancer	8.16e-05	0.000355	CcSEcCtD
Itraconazole—Chest pain—Epirubicin—pancreatic cancer	8.12e-05	0.000353	CcSEcCtD
Itraconazole—Arthralgia—Epirubicin—pancreatic cancer	8.12e-05	0.000353	CcSEcCtD
Itraconazole—Myalgia—Epirubicin—pancreatic cancer	8.12e-05	0.000353	CcSEcCtD
Itraconazole—Anxiety—Epirubicin—pancreatic cancer	8.09e-05	0.000352	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	8.06e-05	0.00035	CcSEcCtD
Itraconazole—Discomfort—Epirubicin—pancreatic cancer	8.02e-05	0.000349	CcSEcCtD
Itraconazole—Malaise—Doxorubicin—pancreatic cancer	7.96e-05	0.000346	CcSEcCtD
Itraconazole—Vertigo—Doxorubicin—pancreatic cancer	7.93e-05	0.000345	CcSEcCtD
Itraconazole—Syncope—Doxorubicin—pancreatic cancer	7.91e-05	0.000344	CcSEcCtD
Itraconazole—Leukopenia—Doxorubicin—pancreatic cancer	7.9e-05	0.000343	CcSEcCtD
Itraconazole—Diarrhoea—Docetaxel—pancreatic cancer	7.89e-05	0.000343	CcSEcCtD
Itraconazole—Confusional state—Epirubicin—pancreatic cancer	7.85e-05	0.000341	CcSEcCtD
Itraconazole—Oedema—Epirubicin—pancreatic cancer	7.78e-05	0.000338	CcSEcCtD
Itraconazole—Anaphylactic shock—Epirubicin—pancreatic cancer	7.78e-05	0.000338	CcSEcCtD
Itraconazole—Loss of consciousness—Doxorubicin—pancreatic cancer	7.75e-05	0.000337	CcSEcCtD
Itraconazole—Infection—Epirubicin—pancreatic cancer	7.73e-05	0.000336	CcSEcCtD
Itraconazole—Cough—Doxorubicin—pancreatic cancer	7.7e-05	0.000335	CcSEcCtD
Itraconazole—Shock—Epirubicin—pancreatic cancer	7.66e-05	0.000333	CcSEcCtD
Itraconazole—Nervous system disorder—Epirubicin—pancreatic cancer	7.63e-05	0.000332	CcSEcCtD
Itraconazole—Dizziness—Docetaxel—pancreatic cancer	7.63e-05	0.000332	CcSEcCtD
Itraconazole—Thrombocytopenia—Epirubicin—pancreatic cancer	7.62e-05	0.000331	CcSEcCtD
Itraconazole—Hypertension—Doxorubicin—pancreatic cancer	7.62e-05	0.000331	CcSEcCtD
Itraconazole—Tachycardia—Epirubicin—pancreatic cancer	7.6e-05	0.00033	CcSEcCtD
Itraconazole—Skin disorder—Epirubicin—pancreatic cancer	7.56e-05	0.000329	CcSEcCtD
Itraconazole—Hyperhidrosis—Epirubicin—pancreatic cancer	7.52e-05	0.000327	CcSEcCtD
Itraconazole—Chest pain—Doxorubicin—pancreatic cancer	7.51e-05	0.000327	CcSEcCtD
Itraconazole—Myalgia—Doxorubicin—pancreatic cancer	7.51e-05	0.000327	CcSEcCtD
Itraconazole—Arthralgia—Doxorubicin—pancreatic cancer	7.51e-05	0.000327	CcSEcCtD
Itraconazole—Anxiety—Doxorubicin—pancreatic cancer	7.49e-05	0.000325	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	7.46e-05	0.000324	CcSEcCtD
Itraconazole—Discomfort—Doxorubicin—pancreatic cancer	7.42e-05	0.000323	CcSEcCtD
Itraconazole—Anorexia—Epirubicin—pancreatic cancer	7.42e-05	0.000322	CcSEcCtD
Itraconazole—Vomiting—Docetaxel—pancreatic cancer	7.34e-05	0.000319	CcSEcCtD
Itraconazole—Rash—Docetaxel—pancreatic cancer	7.27e-05	0.000316	CcSEcCtD
Itraconazole—Hypotension—Epirubicin—pancreatic cancer	7.27e-05	0.000316	CcSEcCtD
Itraconazole—Dermatitis—Docetaxel—pancreatic cancer	7.27e-05	0.000316	CcSEcCtD
Itraconazole—Confusional state—Doxorubicin—pancreatic cancer	7.26e-05	0.000316	CcSEcCtD
Itraconazole—Headache—Docetaxel—pancreatic cancer	7.23e-05	0.000314	CcSEcCtD
Itraconazole—Oedema—Doxorubicin—pancreatic cancer	7.2e-05	0.000313	CcSEcCtD
Itraconazole—Anaphylactic shock—Doxorubicin—pancreatic cancer	7.2e-05	0.000313	CcSEcCtD
Itraconazole—Infection—Doxorubicin—pancreatic cancer	7.15e-05	0.000311	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.09e-05	0.000308	CcSEcCtD
Itraconazole—Shock—Doxorubicin—pancreatic cancer	7.08e-05	0.000308	CcSEcCtD
Itraconazole—Nervous system disorder—Doxorubicin—pancreatic cancer	7.06e-05	0.000307	CcSEcCtD
Itraconazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.05e-05	0.000306	CcSEcCtD
Itraconazole—Insomnia—Epirubicin—pancreatic cancer	7.04e-05	0.000306	CcSEcCtD
Itraconazole—Tachycardia—Doxorubicin—pancreatic cancer	7.03e-05	0.000305	CcSEcCtD
Itraconazole—Skin disorder—Doxorubicin—pancreatic cancer	6.99e-05	0.000304	CcSEcCtD
Itraconazole—Paraesthesia—Epirubicin—pancreatic cancer	6.99e-05	0.000304	CcSEcCtD
Itraconazole—Hyperhidrosis—Doxorubicin—pancreatic cancer	6.96e-05	0.000303	CcSEcCtD
Itraconazole—Dyspnoea—Epirubicin—pancreatic cancer	6.94e-05	0.000302	CcSEcCtD
Itraconazole—Somnolence—Epirubicin—pancreatic cancer	6.92e-05	0.000301	CcSEcCtD
Itraconazole—Anorexia—Doxorubicin—pancreatic cancer	6.86e-05	0.000298	CcSEcCtD
Itraconazole—Nausea—Docetaxel—pancreatic cancer	6.85e-05	0.000298	CcSEcCtD
Itraconazole—Dyspepsia—Epirubicin—pancreatic cancer	6.85e-05	0.000298	CcSEcCtD
Itraconazole—Decreased appetite—Epirubicin—pancreatic cancer	6.77e-05	0.000294	CcSEcCtD
Itraconazole—Hypotension—Doxorubicin—pancreatic cancer	6.73e-05	0.000292	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.72e-05	0.000292	CcSEcCtD
Itraconazole—Fatigue—Epirubicin—pancreatic cancer	6.71e-05	0.000292	CcSEcCtD
Itraconazole—Constipation—Epirubicin—pancreatic cancer	6.66e-05	0.000289	CcSEcCtD
Itraconazole—Pain—Epirubicin—pancreatic cancer	6.66e-05	0.000289	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.56e-05	0.000285	CcSEcCtD
Itraconazole—Insomnia—Doxorubicin—pancreatic cancer	6.51e-05	0.000283	CcSEcCtD
Itraconazole—Paraesthesia—Doxorubicin—pancreatic cancer	6.47e-05	0.000281	CcSEcCtD
Itraconazole—Dyspnoea—Doxorubicin—pancreatic cancer	6.42e-05	0.000279	CcSEcCtD
Itraconazole—Feeling abnormal—Epirubicin—pancreatic cancer	6.41e-05	0.000279	CcSEcCtD
Itraconazole—Somnolence—Doxorubicin—pancreatic cancer	6.4e-05	0.000278	CcSEcCtD
Itraconazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.36e-05	0.000277	CcSEcCtD
Itraconazole—Dyspepsia—Doxorubicin—pancreatic cancer	6.34e-05	0.000276	CcSEcCtD
Itraconazole—Decreased appetite—Doxorubicin—pancreatic cancer	6.26e-05	0.000272	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.22e-05	0.00027	CcSEcCtD
Itraconazole—Fatigue—Doxorubicin—pancreatic cancer	6.21e-05	0.00027	CcSEcCtD
Itraconazole—Urticaria—Epirubicin—pancreatic cancer	6.18e-05	0.000269	CcSEcCtD
Itraconazole—Pain—Doxorubicin—pancreatic cancer	6.16e-05	0.000268	CcSEcCtD
Itraconazole—Constipation—Doxorubicin—pancreatic cancer	6.16e-05	0.000268	CcSEcCtD
Itraconazole—Abdominal pain—Epirubicin—pancreatic cancer	6.15e-05	0.000267	CcSEcCtD
Itraconazole—Body temperature increased—Epirubicin—pancreatic cancer	6.15e-05	0.000267	CcSEcCtD
Itraconazole—Feeling abnormal—Doxorubicin—pancreatic cancer	5.93e-05	0.000258	CcSEcCtD
Itraconazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.89e-05	0.000256	CcSEcCtD
Itraconazole—Hypersensitivity—Epirubicin—pancreatic cancer	5.73e-05	0.000249	CcSEcCtD
Itraconazole—Urticaria—Doxorubicin—pancreatic cancer	5.72e-05	0.000249	CcSEcCtD
Itraconazole—Abdominal pain—Doxorubicin—pancreatic cancer	5.69e-05	0.000247	CcSEcCtD
Itraconazole—Body temperature increased—Doxorubicin—pancreatic cancer	5.69e-05	0.000247	CcSEcCtD
Itraconazole—Asthenia—Epirubicin—pancreatic cancer	5.58e-05	0.000243	CcSEcCtD
Itraconazole—Pruritus—Epirubicin—pancreatic cancer	5.51e-05	0.000239	CcSEcCtD
Itraconazole—Diarrhoea—Epirubicin—pancreatic cancer	5.32e-05	0.000231	CcSEcCtD
Itraconazole—Hypersensitivity—Doxorubicin—pancreatic cancer	5.31e-05	0.000231	CcSEcCtD
Itraconazole—Asthenia—Doxorubicin—pancreatic cancer	5.17e-05	0.000225	CcSEcCtD
Itraconazole—Dizziness—Epirubicin—pancreatic cancer	5.15e-05	0.000224	CcSEcCtD
Itraconazole—Pruritus—Doxorubicin—pancreatic cancer	5.09e-05	0.000221	CcSEcCtD
Itraconazole—Vomiting—Epirubicin—pancreatic cancer	4.95e-05	0.000215	CcSEcCtD
Itraconazole—Diarrhoea—Doxorubicin—pancreatic cancer	4.93e-05	0.000214	CcSEcCtD
Itraconazole—Rash—Epirubicin—pancreatic cancer	4.91e-05	0.000213	CcSEcCtD
Itraconazole—Dermatitis—Epirubicin—pancreatic cancer	4.9e-05	0.000213	CcSEcCtD
Itraconazole—Headache—Epirubicin—pancreatic cancer	4.88e-05	0.000212	CcSEcCtD
Itraconazole—Dizziness—Doxorubicin—pancreatic cancer	4.76e-05	0.000207	CcSEcCtD
Itraconazole—Nausea—Epirubicin—pancreatic cancer	4.62e-05	0.000201	CcSEcCtD
Itraconazole—Vomiting—Doxorubicin—pancreatic cancer	4.58e-05	0.000199	CcSEcCtD
Itraconazole—Rash—Doxorubicin—pancreatic cancer	4.54e-05	0.000197	CcSEcCtD
Itraconazole—Dermatitis—Doxorubicin—pancreatic cancer	4.54e-05	0.000197	CcSEcCtD
Itraconazole—Headache—Doxorubicin—pancreatic cancer	4.51e-05	0.000196	CcSEcCtD
Itraconazole—Nausea—Doxorubicin—pancreatic cancer	4.28e-05	0.000186	CcSEcCtD
